The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.

In a sudden about-face, HHS said it won't slash funding for the Women's Health Initiative, a major research project focused on preventing disease in older women.

For patients with myocardial infarction (MI), early oral combination lipid-lowering therapy (LLT) is beneficial.

The FDA granted Priority Review to lenacapavir for the prevention of HIV as pre-exposure prophylaxis (PrEP). Lenacapavir is a long-acting HIV-1 capsid inhibitor administered as a twice-yearly ...

GLP-1RA use, but not SGLT2i or pioglitazone use, was associated with a statistically significant lower risk for dementia and cognitive impairment.

Dr Marty Makary opened up about his first weeks on the job as FDA commissioner and his vision for the future of the agency.

Florida state lawmakers have approved a bill to ban the addition of fluoride to public drinking water, which could harm dental health.